The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's demand for confidential data.
This move became public following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesman has since clarified that the United States was demanding access to genetic material for research and profit while was unwilling to share the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged further negotiations to reach a agreement acceptable to all parties so the nation's vital HIV programme can be sustained.
Wider Background
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were filed about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost transparency and accountability.
According to reports, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," he stated.
"Put simply, our country would provide the basic resources for medical research with no assurance that the final treatments would be accessible to our citizens should a new health crisis emerge."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its push of one-on-one health agreements were upending frameworks already established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This system is designed to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future collaboration might be designed in a manner that respects the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks should continue since much of the country's HIV programmes were funded by external financing.
"Where specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
The situation emphasises the continuing debate between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.